AI-generated summary
This review discusses how photobiomodulation therapy might steer bone marrow-derived mesenchymal cells toward anti-inflammatory and bone-building activity. The authors report on outcomes of different photobiomodulation protocols applied to these cells. They also note complexities of the approach in living organisms, while describing in vitro approaches as encouraging and feasible.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a review with no stated number of included studies, and the findings are described mainly in vitro with complexities noted for in vivo use.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.